<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/0A32DF0B-F2C5-42D5-A74A-32E1FD6B47D1"><gtr:id>0A32DF0B-F2C5-42D5-A74A-32E1FD6B47D1</gtr:id><gtr:name>University of Massachusetts (UMass)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/C9FF1151-E064-4E1D-9054-B4BBF5A9E5D4"><gtr:id>C9FF1151-E064-4E1D-9054-B4BBF5A9E5D4</gtr:id><gtr:name>Genetech, Inc</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/20E66A18-4A43-4DD5-BA98-5320F6EC9269"><gtr:id>20E66A18-4A43-4DD5-BA98-5320F6EC9269</gtr:id><gtr:name>GlaxoSmithKline (GSK)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/4A9426E3-7F35-48FC-BD72-3776C8F90A4A"><gtr:id>4A9426E3-7F35-48FC-BD72-3776C8F90A4A</gtr:id><gtr:name>Grants Admin Office</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:department>Veterinary Medicine</gtr:department><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/0A32DF0B-F2C5-42D5-A74A-32E1FD6B47D1"><gtr:id>0A32DF0B-F2C5-42D5-A74A-32E1FD6B47D1</gtr:id><gtr:name>University of Massachusetts (UMass)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/C9FF1151-E064-4E1D-9054-B4BBF5A9E5D4"><gtr:id>C9FF1151-E064-4E1D-9054-B4BBF5A9E5D4</gtr:id><gtr:name>Genetech, Inc</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/20E66A18-4A43-4DD5-BA98-5320F6EC9269"><gtr:id>20E66A18-4A43-4DD5-BA98-5320F6EC9269</gtr:id><gtr:name>GlaxoSmithKline (GSK)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/4A9426E3-7F35-48FC-BD72-3776C8F90A4A"><gtr:id>4A9426E3-7F35-48FC-BD72-3776C8F90A4A</gtr:id><gtr:name>Grants Admin Office</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/1B9F6F30-BEEC-4C65-BAB7-78F6632A3AA3"><gtr:id>1B9F6F30-BEEC-4C65-BAB7-78F6632A3AA3</gtr:id><gtr:firstName>Clare</gtr:firstName><gtr:surname>Bryant</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/0908953C-1190-4B93-8480-ED2A91D1A89D"><gtr:id>0908953C-1190-4B93-8480-ED2A91D1A89D</gtr:id><gtr:firstName>Duncan</gtr:firstName><gtr:surname>Maskell</gtr:surname><gtr:orcidId>0000-0002-5065-653X</gtr:orcidId><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/13670E61-2619-42F1-A009-D5CA95D25B8D"><gtr:id>13670E61-2619-42F1-A009-D5CA95D25B8D</gtr:id><gtr:firstName>Pietro</gtr:firstName><gtr:surname>Mastroeni</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=BB%2FH003916%2F1"><gtr:id>4E69F032-9A4C-4CB7-A54B-AF4A7C0EB447</gtr:id><gtr:title>Characterisation of the Pattern Recognition Receptors required for the development of protective immunity against Salmonella infection</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>BB/H003916/1</gtr:grantReference><gtr:abstractText>Salmonella enterica causes a wide range of diseases in many animals. Economic losses to the farming industry through Salmonella infection are potentially very high, but also important is the fact that a number of serovars that infect animals can also cause food poisoning and gastroenteritis in humans. In mice, infection with Salmonella enterica serovar Typhimurium (S. Typhimurium) causes clinical signs that are very similar to those seen in invasive infections of humans and chickens. Infection studies in mice will therefore allow us to understand how infection is likely to develop and spread within other species of animals. Vaccination of animals to lower the levels of Salmonella in meat and eggs will reduce the chances of infection spreading to people. The mouse model of infection is also excellent for studying vaccines. A successful vaccine must be generate a strong immune response but must also be safe for application in young and older individuals. Understanding how Salmonella interacts with its host to generate an immune response is critical when trying to design new vaccines. The animal detects the presence of these bacterial molecules through specialised proteins called Pattern Recognition Receptors (PRRs) which then initiate host defence mechanisms to clear the infection. These receptors are also believed to be important in generating a good response to vaccines, but precisely how this happens is currently unclear. The knowledge on whether chickens, for example, use PRRs to control Salmonella infection is too poorly understood to perform these studies in this species, but we can use mice without PRRs to determine whether these proteins are important for the control of, and protection against, Salmonella. Here we will determine which PRRs are important in protecting mice against Salmonella infections. The impact of this work will be to determine which PRRs are important in generating successful protective immune responses against Salmonella and these data will therefore allow us to design better vaccines for chickens, other domestic animals and humans.</gtr:abstractText><gtr:technicalSummary>Recognition of invading microorganisms by the host is an essential first step in the generation of protective immunity. Various microbial components are known to stimulate a group of receptors collectively known as the Pattern Recognition Receptors (PRR) that include the Toll-like Receptors (TLRs) and Nucleotide-binding domain, Leucine-rich repeat containing Receptors (NLRs). TLRs and NLRs respond to microbial components in different cellular sites and co-ordinated engagement of these receptors leads to intense induction of innate and adaptive immunity. Salmonella enterica is an important bacterial pathogen that causes disease in humans and livestock species. Transmission of some serovars (e.g. Enteritidis and Typhimurium) to humans is in the form of a food-borne zoonosis. To combat human gastroenteritis caused by salmonellae, vaccination of livestock animals to remove the major source of this organism is a more suitable approach than vaccination of people. Current vaccines are not particularly effective so understanding how to induce the most appropriate host immune responses to drive protective anti-Salmonella immunity is critical to optimise vaccination strategies against Salmonella spp. Salmonella can be located in intracellular (in vacuoles) and extracellular compartments but it also uses specialist structures to translocate products directly into the host cell cytoplasm. Hence, molecules derived from Salmonella are available to both the TLR and NLR pathways. PRR biology in domestic animals is in its infancy whereas PRR biology and the tools available to study these receptors in mice are well developed. In this project we will define which PRRs are important in controlling bacterial growth and mounting a protective immune response against infection with S. Typhimurium by infecting mouse strains with engineered deficiencies in the PRR pathways. The impact of this work will be to clearly define which PRRs drive protective anti-Salmonella immunity.</gtr:technicalSummary><gtr:fund><gtr:end>2012-12-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/2512EF1C-401B-4222-9869-A770D4C5FAC7"><gtr:id>2512EF1C-401B-4222-9869-A770D4C5FAC7</gtr:id><gtr:name>BBSRC</gtr:name></gtr:funder><gtr:start>2009-10-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>513435</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Genetech, Inc</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Genentech Visiting Professorship</gtr:description><gtr:id>CDF41EE0-86D3-4CEE-A136-4F91C6418296</gtr:id><gtr:impact>None yet as the work is still in progress</gtr:impact><gtr:outcomeId>58bea1c5e94e86.75233010-1</gtr:outcomeId><gtr:partnerContribution>My collaborators gave me novel reagents and supported my research during my time in the USA</gtr:partnerContribution><gtr:piContribution>I visited Genentech South San Francisco site and performed research in the laboratory there for 9 months. Two of my PhD students also had 3 month internships working with myself and my Genentech collaborators. We learnt new techniques and gained access to new reagents. I intellectually contributed to their inflammasome research program.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>GlaxoSmithKline (GSK)</gtr:collaboratingOrganisation><gtr:country>Global</gtr:country><gtr:description>GSK Immunology Catalyst Sabbatical Award</gtr:description><gtr:id>BCA138FD-863B-4AD4-BEE7-1C0C7D354F7B</gtr:id><gtr:impact>None yet</gtr:impact><gtr:outcomeId>58bea4f2263ab3.75559105-1</gtr:outcomeId><gtr:partnerContribution>GSK bought out my teaching and administration duties for 3 years and fund 2 postdoctoral researchers to work with me at GSK</gtr:partnerContribution><gtr:piContribution>GSK have bought out my teaching and administration duties for 3 years. I spend 3 days a week at GSK and have 2 postdoctoral researchers at GSK. I am working on inflammasome biology and Pattern Recognition Receptor research. I intellectually input into several of the GSK therapeutic units.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Trinity College Dublin</gtr:collaboratingOrganisation><gtr:country>Ireland, Republic of</gtr:country><gtr:description>Luke O'Neill, Trinity College, Dublin</gtr:description><gtr:id>4479A0E1-0017-476A-BACC-EEEF7690693D</gtr:id><gtr:impact>Publications</gtr:impact><gtr:outcomeId>b95f34eeb95f3502-1</gtr:outcomeId><gtr:partnerContribution>Intellectual input
Collaborative discussion
Transfer of new techniques</gtr:partnerContribution><gtr:piContribution>Collaboration with Trinity College, Dublin</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Massachusetts (UMass)</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>University of Massachusetts Medical School</gtr:department><gtr:description>Continued Collaboration with University of Massachusetts Medical Schoo</gtr:description><gtr:id>083D2D91-E3D0-4757-951E-31AD501F042E</gtr:id><gtr:impact>On going provision of reagents has enabled our publications for this grant.</gtr:impact><gtr:outcomeId>b960d6dcb960d6f0-1</gtr:outcomeId><gtr:partnerContribution>Provision of cell lines and reagents. Intellectual discussions about our research work.</gtr:partnerContribution><gtr:piContribution>Continuation of existing collaboration</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Pattern recognition receptors: the key to host recognition of infection or a load of old PAMPs</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>0218E0E7-C16B-469F-9A49-274818C06FD3</gtr:id><gtr:impact>Invited talk Institute for Child Health

no actual impacts realised to date</gtr:impact><gtr:outcomeId>r-7548329418.1044490bb9c0aa</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>What can maths and physics do for infection biology?</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>2325230F-10C3-480C-8180-BBF6F31AA6B8</gtr:id><gtr:impact>Invited talk

no actual impacts realised to date</gtr:impact><gtr:outcomeId>r-2237907380.0872150c25de52</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Lafferty Debate participant</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>F15CDD21-CF23-4569-8A8E-77065B0B41C6</gtr:id><gtr:impact>Participated in a public debate on &amp;quot;Adaptive Immunity is innately redundant&amp;quot;</gtr:impact><gtr:outcomeId>58bebfd38e8595.88528426</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other audiences</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Pattern recognition receptors: therapeutic targets for allergic as well as infectious diseases</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>EFDAFF97-C880-4B16-94D3-6D62F19DD8E7</gtr:id><gtr:impact>Invited talk CIMR

no actual impacts realised to date</gtr:impact><gtr:outcomeId>r-4880253127.6645630cdc0858</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research or patient groups</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Pattern recognition receptors: the key to host recognition of infection or a load of old PAMPs</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>42CF7171-247C-4642-A7EA-62BF44AF8701</gtr:id><gtr:impact>Invited talk

no actual impacts realised to date</gtr:impact><gtr:outcomeId>r-2958661842.1214280bb98482</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>There are 100 trillion Bacteria in Your Gut: How do we protect ourselves against infection?</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>5CEA5A7D-4E71-4545-8E17-B6C802A75E9D</gtr:id><gtr:impact>Public talk to the Society of Biology Public lecture to the Society for Biology in Cambridge

no actual impacts realised to date</gtr:impact><gtr:outcomeId>r-4906380050.7284520cdb368a</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Recognition of bacterial infection by Pattern recognition receptors</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>DD87B6C4-3E3D-4445-942A-630D9E7753C9</gtr:id><gtr:impact>Invited talk NIAID/NIH

no actual impacts realised to date</gtr:impact><gtr:outcomeId>r-3313191564.11401130becc90a</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research or patient groups</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Laser tweezers picking up bacteria</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>regional</gtr:geographicReach><gtr:id>F091906E-B7AA-48AC-9AE7-90D72DC9D1A7</gtr:id><gtr:impact>Interview on the Naked Scientists Radio Show, Radio Cambridgeshire

no actual impacts realised to date</gtr:impact><gtr:outcomeId>r-3773343967.06274180bbeaeda</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.thenakedscientists.com/HTML/content/interviews/interview/1358/</gtr:url><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>University of Maryland, USA: Pattern recognition receptors: the key to host recognition of infection or a load of old PAMPs</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>F53F8635-F6AB-4903-8005-E5BE0BC76ABC</gtr:id><gtr:impact>Invited talk at University of Maryland, USA

no actual impacts realised to date</gtr:impact><gtr:outcomeId>r-8380735803.7500980cdc10c8</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Pattern recognition receptors: the key to host recognition of infection or a load of old PAMPs</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>97692C9A-8CA3-4A56-BFE9-8611C220A5D4</gtr:id><gtr:impact>Invited talk

no actual impacts realised to date</gtr:impact><gtr:outcomeId>r-5593890711.2869350ba29d58</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research or patient groups</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Recognition of bacterial infection by Pattern recognition receptors</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>F0EDE52C-2EB2-465C-BE9B-0F9EC20763EE</gtr:id><gtr:impact>Invited talk

no actual impacts realised to date</gtr:impact><gtr:outcomeId>r-9495653593.4430120be9c868</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research or patient groups</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Pattern recognition receptors: the key to host recognition of infection or a load of old PAMPs</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>7FFA2A8A-E3F6-4024-9D10-0014DA527DAE</gtr:id><gtr:impact>Invited talk

no actual impacts realised to date</gtr:impact><gtr:outcomeId>r-3021184329.89454270ba23ce6</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>There are 100 trillion Bacteria in Your Gut: How do we protect ourselves against infection?</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>76FD6A8E-E9DF-4449-B7B0-66B3AC9D7789</gtr:id><gtr:impact>Talk to public at Queens' College Academic Saturday alumni event Public communication on how bacteria are recognised by the host: includes the research work on this BBSRC funded project

no actual impacts realised to date</gtr:impact><gtr:outcomeId>r-674616220.10415070c2542a8</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>There are 100 trillion Bacteria in Your Gut: How do we protect ourselves against infection?</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>F4098ECA-C341-4942-A6B6-11FC71432188</gtr:id><gtr:impact>Lecture to year 12 school children Public lecture including research funded by this BBSRC grant

no actual impacts realised to date</gtr:impact><gtr:outcomeId>r-6395825358.4763270cc311c2</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>917208</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Effects of Nod-like receptor activity on protective immunity against Salmonella infection</gtr:description><gtr:end>2016-12-02</gtr:end><gtr:fundingOrg>Biotechnology and Biological Sciences Research Council (BBSRC)</gtr:fundingOrg><gtr:fundingRef>BB/K006436/1</gtr:fundingRef><gtr:id>D50C679D-2E65-43AC-9340-1E00E6260F9A</gtr:id><gtr:outcomeId>5ee5841a5ee5842e</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>226000</gtr:amountPounds><gtr:country>Global</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Elion and Black Immunology Catalyst Sabbatical Award</gtr:description><gtr:end>2019-10-02</gtr:end><gtr:fundingOrg>GlaxoSmithKline (GSK)</gtr:fundingOrg><gtr:id>95280957-CC73-44D4-90D6-56529ECCC73B</gtr:id><gtr:outcomeId>56c3aee548a740.84843292</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2016-11-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>255019</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>A mathematical and biophysical analysis of salmonella-macrophage interactions</gtr:description><gtr:end>2013-09-02</gtr:end><gtr:fundingOrg>Biotechnology and Biological Sciences Research Council (BBSRC)</gtr:fundingOrg><gtr:fundingRef>BB/H021930/1</gtr:fundingRef><gtr:id>2032F4B5-90B5-4F93-85AC-1F3B7F30B4BF</gtr:id><gtr:outcomeId>5ee4ee885ee4ee9c</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2010-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>267000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Royal Society Wolfson Refurbishment Scheme</gtr:description><gtr:end>2018-02-02</gtr:end><gtr:fundingOrg>The Royal Society</gtr:fundingOrg><gtr:id>99B673E4-A76E-41C3-B8C4-C091AB4BA1FA</gtr:id><gtr:outcomeId>56b289997518d2.05135438</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-03-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs><gtr:impactSummaryOutput><gtr:description>Our findings have generated impact in several ways
1. Many of the observations made during the grant were used in communications to both the scientific community and the general public
2. Our findings were published in scientific journals
3. Our findings were the basis of two follow up grants: one to further understand how Salmonella vaccines may be generated for chickens and as a basis for an BBSRC Research Development fellowship to Bryant to develop collaborations with mathematicians and physicists
4. We hosted several school children in the lab teaching them about Salmonella.</gtr:description><gtr:firstYearOfImpact>2009</gtr:firstYearOfImpact><gtr:id>602E37D6-1D1C-4EAB-88CA-8C92BB351D34</gtr:id><gtr:impactTypes><gtr:impactType>Societal,Economic</gtr:impactType></gtr:impactTypes><gtr:outcomeId>54579fa410b0e7.07467079</gtr:outcomeId><gtr:sector>Agriculture, Food and Drink,Education</gtr:sector></gtr:impactSummaryOutput></gtr:impactSummaryOutputs><gtr:intellectualPropertyOutputs/><gtr:keyFindingsOutput><gtr:description>Salmonella enterica causes a wide range of diseases in many animals. Economic losses to the farming industry through Salmonella infection are potentially very high, but also important is the fact that a number of serovars that infect animals can also cause food poisoning and gastroenteritis in humans. Vaccination of animals to lower the levels of Salmonella in meat and eggs will reduce the chances of infection spreading to people. A successful vaccine must generate a strong adaptive immune response but must also be safe for application in young and older individuals. Understanding how Salmonella interacts with its host to generate an immune response is critical when trying to design new vaccines.

Animals detect the presence of molecules on the bacteria through specialised proteins called Pattern Recognition Receptors (PRRs) which then initiate host defence mechanisms to clear the infection. These receptors are also believed to be important in generating a good response to vaccines, but precisely how this happens is currently unclear. In this grant we aimed to determine which PRRs are important for initiating bacterial clearance and for driving adaptive immune responses against Salmonella infections. 

The following key findings were made during this project:

1. The PRR Toll-like receptor 4 (TLR4) plays an important role in clearance of, and the induction of effective adaptive TH1 immune responses against, Salmonella Typhimurium. The TH1 response developed by cells without TLR4 is markedly reduced because of defective dendritic cell function.

2. The PRRs Nod-like receptors NLRP3 and NLRC4, through activation of the effector protein casapse 1, contribute to controlling the numbers of salmonellae. 

3. Activation of NLRC4 dampens the adaptive TH1 immune responses against Salmonella Typhimurium. NLRC4 dampens TH1 immunity independently of caspase-1 identifying a novel mechanism by which anti-Salmonella adaptive immune responses are controlled. 

Our work suggests that PRR activity makes an important contribution to the immune responses generated against Salmonella. Some PRRs enhance adaptive immunity whilst others suppress it therefore these data will allow us to design better vaccines for chickens, other domestic animals and humans.</gtr:description><gtr:exploitationPathways>1. Generation of an optimal live attenuated vaccine

2. Data have been used for multiple presentations to the public to increase understanding of how animals detect bacteria. This work has clarified how PRRs contribute to the protective immune response against Salmonella infections. The information gained in this grant will allow us to design genetically modified salmonellae to give a live attenuated vaccine with modified bacterial PRR ligands such that the maximum protective immunity against this bacterum can be achieved.</gtr:exploitationPathways><gtr:id>307A5107-633A-45BE-BA6E-FFA852109890</gtr:id><gtr:outcomeId>r-1063626791.4098006774af1de</gtr:outcomeId><gtr:sectors><gtr:sector>Education,Pharmaceuticals and Medical Biotechnology</gtr:sector></gtr:sectors><gtr:url>http://www.vet.cam.ac.uk/directory/ceb27@cam.ac.uk</gtr:url></gtr:keyFindingsOutput><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>A8A9CFAA-93FC-4775-BAF0-B1AF7BECD922</gtr:id><gtr:title>Salmonella enterica serovar typhimurium trxA mutants are protective against virulent challenge and induce less inflammation than the live-attenuated vaccine strain SL3261.</gtr:title><gtr:parentPublicationTitle>Infection and immunity</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/901d7641b11f3c82d6a3edd12088d655"><gtr:id>901d7641b11f3c82d6a3edd12088d655</gtr:id><gtr:otherNames>Peters SE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0019-9567</gtr:issn><gtr:outcomeId>doi_53d07007096426cf</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AA867D3B-4789-48FF-8DDA-302365B87623</gtr:id><gtr:title>Salmonella infection induces recruitment of Caspase-8 to the inflammasome to modulate IL-1? production.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/233be6778cd6f4d7cdaf183640ad78de"><gtr:id>233be6778cd6f4d7cdaf183640ad78de</gtr:id><gtr:otherNames>Man SM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>544531ab31eec1.34420211</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>13CF037C-1232-4DC4-BBF6-5B6C0C8AF84B</gtr:id><gtr:title>Caspase-8 functions as a key mediator of inflammation and pro-IL-1&amp;Icirc;&amp;sup2; processing via both canonical and non-canonical pathways.</gtr:title><gtr:parentPublicationTitle>Immunological reviews</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2bdbcc6c899882f237eac5d622f63da8"><gtr:id>2bdbcc6c899882f237eac5d622f63da8</gtr:id><gtr:otherNames>Monie TP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0105-2896</gtr:issn><gtr:outcomeId>5675e2814033a</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6781DAB3-A36A-4C95-AA56-D173112521DB</gtr:id><gtr:title>MyD88 adaptor-like is not essential for TLR2 signaling and inhibits signaling by TLR3.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/dd672319b0671313400b44b664ab240a"><gtr:id>dd672319b0671313400b44b664ab240a</gtr:id><gtr:otherNames>Kenny EF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>pm_5435a895a8988c929</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5A2221D2-4E5D-4D69-8717-F713501CB22D</gtr:id><gtr:title>The N-terminal loop of IRAK-4 death domain regulates ordered assembly of the Myddosome signalling scaffold.</gtr:title><gtr:parentPublicationTitle>Scientific reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/20aac4c0b3cd57f1030522a8d2951464"><gtr:id>20aac4c0b3cd57f1030522a8d2951464</gtr:id><gtr:otherNames>Dossang AC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2045-2322</gtr:issn><gtr:outcomeId>58af2a8cef7720.15256629</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A807835D-FB99-4133-B408-F36A2E293719</gtr:id><gtr:title>Mitogen-activated protein kinases (MAPKs) are modulated during Francisella tularensis infection, but inhibition of extracellular-signal-regulated kinases (ERKs) is of limited therapeutic benefit.</gtr:title><gtr:parentPublicationTitle>European journal of clinical microbiology &amp; infectious diseases : official publication of the European Society of Clinical Microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/07c482173eb01a10263e8f9383b9cc27"><gtr:id>07c482173eb01a10263e8f9383b9cc27</gtr:id><gtr:otherNames>Saint RJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0934-9723</gtr:issn><gtr:outcomeId>58af2ae209a588.31407263</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B2FE8941-F0FD-484B-B3A4-1D50946420BD</gtr:id><gtr:title>Actin polymerization as a key innate immune effector mechanism to control Salmonella infection.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/233be6778cd6f4d7cdaf183640ad78de"><gtr:id>233be6778cd6f4d7cdaf183640ad78de</gtr:id><gtr:otherNames>Man SM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>5675dd0d71fab</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EC2DF4D9-03A3-4683-9598-B2BCCA00E738</gtr:id><gtr:title>The COP II adaptor protein TMED7 is required to initiate and mediate the delivery of TLR4 to the plasma membrane.</gtr:title><gtr:parentPublicationTitle>Science signaling</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b6259d72b204377289e1ffe0a6957849"><gtr:id>b6259d72b204377289e1ffe0a6957849</gtr:id><gtr:otherNames>Liaunardy-Jopeace A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1945-0877</gtr:issn><gtr:outcomeId>585d76b5283450.32019321</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C2379CEE-A1D1-4121-806B-4063860ABC2E</gtr:id><gtr:title>Salmonella enterica serovar Typhimurium mutants completely lacking the F(0)F(1) ATPase are novel live attenuated vaccine strains.</gtr:title><gtr:parentPublicationTitle>Vaccine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/287f1a39a9436aed6dc11e1d7c156766"><gtr:id>287f1a39a9436aed6dc11e1d7c156766</gtr:id><gtr:otherNames>Northen H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0264-410X</gtr:issn><gtr:outcomeId>m_2650016642139840aa</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9FF3280B-C707-4886-A88A-8BF47FB39C3F</gtr:id><gtr:title>Multiple redundant stress resistance mechanisms are induced in Salmonella enterica serovar Typhimurium in response to alteration of the intracellular environment via TLR4 signalling.</gtr:title><gtr:parentPublicationTitle>Microbiology (Reading, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ff27d3c57c1ae245ae51b1a5939da084"><gtr:id>ff27d3c57c1ae245ae51b1a5939da084</gtr:id><gtr:otherNames>Wright JA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1350-0872</gtr:issn><gtr:outcomeId>doi_55f949949d1bd21e</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>38C461E0-7FFB-48E6-BDA9-F34DDA27D484</gtr:id><gtr:title>Toll-like receptor 4 signalling through MyD88 is essential to control Salmonella enterica serovar typhimurium infection, but not for the initiation of bacterial clearance.</gtr:title><gtr:parentPublicationTitle>Immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5341066923085968e5bad3616f730a71"><gtr:id>5341066923085968e5bad3616f730a71</gtr:id><gtr:otherNames>Talbot S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0019-2805</gtr:issn><gtr:outcomeId>doi_55f949949d25e599</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>55BA1E9D-5402-4D23-8462-914743F31DDD</gtr:id><gtr:title>CARD9 negatively regulates NLRP3-induced IL-1? production on Salmonella infection of macrophages.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4d6655093a5bc86957efe50b469eaf7b"><gtr:id>4d6655093a5bc86957efe50b469eaf7b</gtr:id><gtr:otherNames>Pereira M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn><gtr:outcomeId>588b22395a4d42.57988099</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F4E3DA7F-C385-4981-A05B-608A765F66D4</gtr:id><gtr:title>Pattern recognition receptors in equine endotoxaemia and sepsis.</gtr:title><gtr:parentPublicationTitle>Equine veterinary journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/794909ec062cc5be66fb27920d527e2f"><gtr:id>794909ec062cc5be66fb27920d527e2f</gtr:id><gtr:otherNames>Werners AH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0425-1644</gtr:issn><gtr:outcomeId>pm_53cc009c00949c74b</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>444D3B82-AC4D-4585-B797-B85DC7DD4A4B</gtr:id><gtr:title>The molecular basis of the host response to lipopolysaccharide.</gtr:title><gtr:parentPublicationTitle>Nature reviews. Microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/dc38ddc2aa13707bc8b3e3c7d2d3829c"><gtr:id>dc38ddc2aa13707bc8b3e3c7d2d3829c</gtr:id><gtr:otherNames>Bryant CE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1740-1526</gtr:issn><gtr:outcomeId>pm_53cbfb1bfb1b48f97</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>828EBF28-10D6-4186-A85B-0E8F454BDD9B</gtr:id><gtr:title>MAP kinase phosphatase-2 plays a critical role in response to infection by Leishmania mexicana.</gtr:title><gtr:parentPublicationTitle>PLoS pathogens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c536613c5c0a7eacef5e5dfe9b163109"><gtr:id>c536613c5c0a7eacef5e5dfe9b163109</gtr:id><gtr:otherNames>Al-Mutairi MS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1553-7366</gtr:issn><gtr:outcomeId>pm_5435a895a897c83e9</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C47C2EFC-5E36-4ECE-A641-8D473BAC017D</gtr:id><gtr:title>Mice, men and the relatives: cross-species studies underpin innate immunity.</gtr:title><gtr:parentPublicationTitle>Open biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/dc38ddc2aa13707bc8b3e3c7d2d3829c"><gtr:id>dc38ddc2aa13707bc8b3e3c7d2d3829c</gtr:id><gtr:otherNames>Bryant CE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>2046-2441</gtr:issn><gtr:outcomeId>pm_53cc00cc00c706485</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FEE0DDE4-3BFE-4ED9-BC2F-D90CEBBE1753</gtr:id><gtr:title>Inflammasome activation causes dual recruitment of NLRC4 and NLRP3 to the same macromolecular complex.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/233be6778cd6f4d7cdaf183640ad78de"><gtr:id>233be6778cd6f4d7cdaf183640ad78de</gtr:id><gtr:otherNames>Man SM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>doi_55f94b94bf831951</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">BB/H003916/1</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects/><gtr:researchTopics><gtr:researchTopic><gtr:id>D05BC2E0-0345-4A3F-8C3F-775BC42A0819</gtr:id><gtr:text>Unclassified</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>